Unknown

Dataset Information

0

Design, Synthesis and Bioactive Evaluation of Oxime Derivatives of Dehydrocholic Acid as Anti-Hepatitis B Virus Agents.


ABSTRACT: Oxime derivatives of dehydrocholic acid and its esters were designed for anti-hepatitis B virus (HBV) drugs according to principles of assembling active chemical fragments. Twelve compounds were synthesized from dehydrocholic acid by esterification and oxime formation, and their anti-hepatitis B virus (HBV) activities were evaluated with HepG 2.2.15 cells. Results showed that 5 compounds exhibited more effective inhibition of HBeAg than positive control, among them 2b-3 and 2b-1 showed significant anti-HBV activities on inhibiting secretion of HBeAg (IC50 (2b-3) = 49.39 ± 12.78 ?M, SI (2b-3) = 11.03; IC50 (2b-1) = 96.64 ± 28.99 ?M, SI (2b-1) = 10.35) compared to the Entecavir (IC50 = 161.24 ?M, SI = 3.72). Molecular docking studies showed that most of these compounds interacted with protein residues of heparan sulfate proteoglycan (HSPG) in host hepatocyte and bile acid receptor.

SUBMITTER: Wei Z 

PROVIDER: S-EPMC7435646 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2019-01-01 | S-EPMC6600592 | BioStudies
2014-01-01 | S-EPMC4050313 | BioStudies
2014-01-01 | S-EPMC6495540 | BioStudies
2018-01-01 | S-EPMC6017342 | BioStudies
1000-01-01 | S-EPMC6270206 | BioStudies
2005-01-01 | S-EPMC4315949 | BioStudies
2011-01-01 | S-EPMC3130517 | BioStudies
2004-01-01 | S-EPMC4724926 | BioStudies
2012-01-01 | S-EPMC7114352 | BioStudies
2020-01-01 | S-EPMC7136184 | BioStudies